𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN14 THE COST AND COST EFFECTIVENESS OF DASATINIB (SPRYCEL) 100 MG THERAPY FOR THE MANAGEMENT OF IMATINIB RESISTANT AND INTOLERANT PATIENTS IN CHRONIC PHASE WITH CHRONIC MYELOID LEUKEMIA (CML) IN MÉXICO

✍ Scribed by Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Litalien, G; Donato, B


Book ID
122001945
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
64 KB
Volume
12
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES